A multicenter study of rituximab-based regimen as first-line treatment in patients with follicular lymphoma.
- Author:
Jianqiu WU
1
;
Yongping SONG
;
Liping SU
;
Mingzhi ZHANG
;
Wei LI
;
Yu HU
;
Xiaohong ZHANG
;
Yuhuan GAO
;
Zuoxing NIU
;
Ru FENG
;
Wei WANG
;
Jiewen PENG
;
Xiaolin LI
;
Xuenong OUYANG
;
Changping WU
;
Weijing ZHANG
;
Yun ZENG
;
Zhen XIAO
;
Yingmin LIANG
;
Yongzhi ZHUANG
;
Jishi WANG
;
Zimin SUN
;
Hai BAI
;
Tongjian CUI
;
Jifeng FENG
1
Author Information
- Publication Type:Journal Article
- MeSH: Antibodies, Monoclonal, Murine-Derived; therapeutic use; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Humans; Lymphoma, Follicular; drug therapy; Rituximab
- From: Chinese Journal of Hematology 2014;35(5):456-458
- CountryChina
- Language:Chinese
